MASI

Lobbying Update: $80,000 of MASIMO CORPORATION lobbying was just disclosed

$80,000 of MASIMO CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology and telehealth Medicare coverage
Issues related to intellectual property and anti-competitive behavior in the medical device supply chain
Issues related to increased tariffs"

You can find more data on corporate lobbying on Quiver Quantitative.

MASI Hedge Fund Activity

We have seen 167 institutional investors add shares of MASI stock to their portfolio, and 166 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.


This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.